[go: up one dir, main page]

FR2816847B1 - Biomateriaux polymeriques poreux, procede de preparation et utilisations - Google Patents

Biomateriaux polymeriques poreux, procede de preparation et utilisations

Info

Publication number
FR2816847B1
FR2816847B1 FR0015065A FR0015065A FR2816847B1 FR 2816847 B1 FR2816847 B1 FR 2816847B1 FR 0015065 A FR0015065 A FR 0015065A FR 0015065 A FR0015065 A FR 0015065A FR 2816847 B1 FR2816847 B1 FR 2816847B1
Authority
FR
France
Prior art keywords
preparation
porous polymeric
polymeric biomaterials
biomaterials
porous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0015065A
Other languages
English (en)
Other versions
FR2816847A1 (fr
Inventor
Vincent Boudy
Alexandre Laurent
Denis Labarre
Jean Claude Chaumeil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0015065A priority Critical patent/FR2816847B1/fr
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Priority to PCT/FR2001/003623 priority patent/WO2002041928A1/fr
Priority to IL15605001A priority patent/IL156050A0/xx
Priority to AU2002220795A priority patent/AU2002220795A1/en
Priority to EP01997318A priority patent/EP1335759A1/fr
Priority to US10/432,389 priority patent/US20040071776A1/en
Priority to CA002432804A priority patent/CA2432804A1/fr
Publication of FR2816847A1 publication Critical patent/FR2816847A1/fr
Application granted granted Critical
Publication of FR2816847B1 publication Critical patent/FR2816847B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
FR0015065A 2000-11-22 2000-11-22 Biomateriaux polymeriques poreux, procede de preparation et utilisations Expired - Fee Related FR2816847B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0015065A FR2816847B1 (fr) 2000-11-22 2000-11-22 Biomateriaux polymeriques poreux, procede de preparation et utilisations
IL15605001A IL156050A0 (en) 2000-11-22 2001-11-19 Porous polymeric biomaterials, preparation method and uses
AU2002220795A AU2002220795A1 (en) 2000-11-22 2001-11-19 Porous polymeric biomaterials, preparation method and uses
EP01997318A EP1335759A1 (fr) 2000-11-22 2001-11-19 Biomateriaux polymeres poreux, procede de preparation et utilisations
PCT/FR2001/003623 WO2002041928A1 (fr) 2000-11-22 2001-11-19 Biomateriaux polymeres poreux, procede de preparation et utilisations
US10/432,389 US20040071776A1 (en) 2000-11-22 2001-11-19 Porous plymeric biomaterials, preparation method and uses
CA002432804A CA2432804A1 (fr) 2000-11-22 2001-11-19 Biomateriaux polymeres poreux, procede de preparation et utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0015065A FR2816847B1 (fr) 2000-11-22 2000-11-22 Biomateriaux polymeriques poreux, procede de preparation et utilisations

Publications (2)

Publication Number Publication Date
FR2816847A1 FR2816847A1 (fr) 2002-05-24
FR2816847B1 true FR2816847B1 (fr) 2006-07-14

Family

ID=8856749

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0015065A Expired - Fee Related FR2816847B1 (fr) 2000-11-22 2000-11-22 Biomateriaux polymeriques poreux, procede de preparation et utilisations

Country Status (7)

Country Link
US (1) US20040071776A1 (fr)
EP (1) EP1335759A1 (fr)
AU (1) AU2002220795A1 (fr)
CA (1) CA2432804A1 (fr)
FR (1) FR2816847B1 (fr)
IL (1) IL156050A0 (fr)
WO (1) WO2002041928A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1730516A1 (fr) * 2004-03-30 2006-12-13 Pfizer Products Incorporated Procede et dispositif pour l'evaluation de compositions pharmaceutiques
DE102004019241A1 (de) * 2004-04-16 2005-11-03 Cellmed Ag Injizierbare vernetzte und unvernetzte Alginate und ihre Verwendung in der Medizin und in der ästhetischen Chirurgie
AU2007224138B2 (en) * 2006-03-01 2012-07-19 Fmc Biopolymer As Gelled composite
US20100062073A1 (en) * 2006-11-29 2010-03-11 Ronald Arthur Beyerinck Pharmaceutical compositions comprising nanoparticles comprising enteric polymers casein
WO2008125940A2 (fr) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticules comprenant un médicament non cristallin
WO2008135828A2 (fr) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules comprenant un médicament, de l'éthylcellulose et un sel biliaire
WO2008135855A2 (fr) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticules contenant un inhibiteur de la protéine de transfert d'ester de cholestéryle et un polymère non ionisable
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
US8147769B1 (en) * 2007-05-16 2012-04-03 Abbott Cardiovascular Systems Inc. Stent and delivery system with reduced chemical degradation
WO2008149230A2 (fr) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticules comprenant un médicament, un polymère cellulosique non ionisable et du tocophéryl polyéthylène glycol succinate
EP2162120B1 (fr) * 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticules comportant un polymère cellulosique non ionisable et un copolymère bloc amphiphile non ionisable
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
WO2009073216A1 (fr) * 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticules comprenant un polymère non ionisable et un copolymère de méthacrylate fonctionnalisé par amine
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2011044236A1 (fr) 2009-10-06 2011-04-14 Regents Of The University Of Minnesota Microsphères d'embolisation biorésorbables
US8936795B2 (en) 2012-12-19 2015-01-20 Regents Of The University Of Minnesota Liquid embolic material including carboxymethyl chitosan crosslinked with carboxymethyl cellulose
EP2764876A1 (fr) * 2013-02-11 2014-08-13 Lacerta Technologies Inc. Matériau de substitution osseuse avec revêtement biologiquement actif
US10182979B2 (en) 2016-03-22 2019-01-22 Regents Of The University Of Minnesota Biodegradable microspheres
KR101710639B1 (ko) * 2016-06-07 2017-03-08 주식회사 파마리서치프로덕트 핵산, 키토산 및 히알루론산을 포함하는 조직 증강용 충전 조성물 및 이의 제조방법
CN110368528B (zh) * 2019-06-12 2021-01-29 北京大学口腔医学院 一种可注射多孔微芯片及其多级分时递送载体的制备方法
CN116870243B (zh) * 2023-08-10 2024-01-19 广州创赛生物医用材料有限公司 一种具有止血抗炎作用的水凝胶及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1295796C (fr) * 1984-03-27 1992-02-18 Conrad Whyne Matrice biodegradable et methode de production de la matrice
US5529914A (en) * 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
FR2676927B1 (fr) * 1991-05-29 1995-06-23 Ibf Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant.
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
WO1996010374A1 (fr) * 1994-10-03 1996-04-11 Otogen Corporation Implants biomedicaux a biodegradabilite differentielle
US6110484A (en) * 1998-11-24 2000-08-29 Cohesion Technologies, Inc. Collagen-polymer matrices with differential biodegradability
US7004977B2 (en) * 1999-11-24 2006-02-28 A Enterprises, Inc. Soft tissue substitute and method of soft tissue reformation

Also Published As

Publication number Publication date
IL156050A0 (en) 2003-12-23
FR2816847A1 (fr) 2002-05-24
EP1335759A1 (fr) 2003-08-20
WO2002041928A1 (fr) 2002-05-30
AU2002220795A1 (en) 2002-06-03
CA2432804A1 (fr) 2002-05-30
US20040071776A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
FR2816847B1 (fr) Biomateriaux polymeriques poreux, procede de preparation et utilisations
DE60118790D1 (de) Polymere biomaterialien, die silsesquioxan-monomere enthalten
AU4690201A (en) Crosslinked polymer, process for producing the same, absorbent structure, and absorbent article
FR2858634B1 (fr) Nontisse ultrafin, poreux et mecaniquement stable, son procede de fabrication et son utilisation
FR2784107B1 (fr) Microfibrilles de cellulose a surface modifiee, leur procede de preparation, et leur utilisation
DE60218202D1 (de) Poröse polymerprosthesen und deren herstellungsverfahren
EP1027924A4 (fr) Photocatalyseur, procede de production correspondant et elements multifonctionnels
EP1358255A4 (fr) Polymeres poreux
FR2807052B1 (fr) Compositions silico-acryliques, leur procede de preparation et leur utilisation
MXPA02006297A (es) Metodo para la produccion de una hoja de polimero reticulado poroso.
EP1304337A4 (fr) Procede de formation de cellulose
PL360259A1 (en) Process for producing porous polymer
AU2001280572A1 (en) System and methods for web resource discovery
EP0978524A4 (fr) Polymere fluore, son procede de preparation et son utilisation
EP1340736A4 (fr) Materiau absorbant phonique poreux et son procede de production
ID29177A (id) Proses pembuatan urea
FR2816609B1 (fr) Solides inorganiques mesoporeux, leur procede de preparation et leurs utilisations notamment comme catalyseurs et absorbants
EP1300256A4 (fr) Imprime, son application et son procede de fabrication
EP1324238A4 (fr) Procede de distribution
EP0997450A4 (fr) PROCEDE DE REDUCTION DE NO x
AU2531400A (en) Biodegradable, porous shaped bodies
EP1270601A4 (fr) Procede de production d'un polymere poreux
EP1325904A4 (fr) Nouveaux composes aliphatiques, procede de preparation et utilisation associes
FR2813886B1 (fr) Resines novolaques, leur procede de preparation et leurs utilisations
EP1237001A4 (fr) Procede de criblage

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140731